199 related articles for article (PubMed ID: 26861246)
1. Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study.
Deppisch C; Herrmann G; Graepler-Mainka U; Wirtz H; Heyder S; Engel C; Marschal M; Miller CC; Riethmüller J
Infection; 2016 Aug; 44(4):513-20. PubMed ID: 26861246
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment.
Jöbsis Q; Raatgeep HC; Schellekens SL; Kroesbergen A; Hop WC; de Jongste JC
Eur Respir J; 2000 Jul; 16(1):95-100. PubMed ID: 10933092
[TBL] [Abstract][Full Text] [Related]
3. Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients.
Yaacoby-Bianu K; Gur M; Toukan Y; Nir V; Hakim F; Geffen Y; Bentur L
Pediatr Infect Dis J; 2018 Apr; 37(4):336-338. PubMed ID: 28885458
[TBL] [Abstract][Full Text] [Related]
4. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Greally P; Whitaker P; Peckham D
Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
[TBL] [Abstract][Full Text] [Related]
5. A phase I clinical study of inhaled nitric oxide in healthy adults.
Miller C; Miller M; McMullin B; Regev G; Serghides L; Kain K; Road J; Av-Gay Y
J Cyst Fibros; 2012 Jul; 11(4):324-31. PubMed ID: 22520076
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
Zabner R; Quinn JP
Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
[TBL] [Abstract][Full Text] [Related]
7. Infections in patients with cystic fibrosis: diagnostic microbiology update.
Gilligan PH
Clin Lab Med; 2014 Jun; 34(2):197-217. PubMed ID: 24856524
[TBL] [Abstract][Full Text] [Related]
8. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.
Elizur A; Orscheln RC; Ferkol TW; Atkinson JJ; Dunne WM; Buller RS; Armstrong JR; Mardis ER; Storch GA; Cannon CL
Chest; 2007 Jun; 131(6):1718-25. PubMed ID: 17400676
[TBL] [Abstract][Full Text] [Related]
9. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
[TBL] [Abstract][Full Text] [Related]
10. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
11. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
[TBL] [Abstract][Full Text] [Related]
12. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G
J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535
[TBL] [Abstract][Full Text] [Related]
13. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
14. Respiratory bacterial infections in cystic fibrosis.
Ciofu O; Hansen CR; Høiby N
Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
[TBL] [Abstract][Full Text] [Related]
15. Inhaled liposomal amikacin.
Waters V; Ratjen F
Expert Rev Respir Med; 2014 Aug; 8(4):401-9. PubMed ID: 24882271
[TBL] [Abstract][Full Text] [Related]
16. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation in cystic fibrosis patients with difficult to treat lung infections.
Dupont L
Curr Opin Pulm Med; 2017 Nov; 23(6):574-579. PubMed ID: 28858970
[TBL] [Abstract][Full Text] [Related]
18. Current dilemmas in antimicrobial therapy in cystic fibrosis.
Jain K; Smyth AR
Expert Rev Respir Med; 2012 Aug; 6(4):407-22. PubMed ID: 22971066
[TBL] [Abstract][Full Text] [Related]
19. Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.
Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Abraham WR; Höfle MG
J Clin Microbiol; 2015 Sep; 53(9):2900-7. PubMed ID: 26135861
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
Javadpour S; Jones A; Brownlee K
Ir Med J; 2007; 100(7):529-32. PubMed ID: 17886526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
